NR5A2 and breast carcinoma: LRH-1 expression is frequently detected in breast tumours and surrounding adipose tissue, and expression of LRH-1 with estrogen receptor α (ERα) is positively associated in human breast carcinoma tissues and in breast cancer cell lines (26–29).